MICHAEL THRUANGSNGA-KENT: Open Payments
NPI 1871263244 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 15 payments from 6 companies in 2025. Trend: 2023 $242 · 2024 $173 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $331 |
| Ferring Pharmaceuticals Inc. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| Endo USA, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: GEMTESA, ADSTILADRIN, LYNPARZA, AVEED, iTIND System, ORGOVYX, ERLEADA.
Industry payments across AK — which companies pay providers there.
